Basics Vaxcyte, Inc. IPO Date: July 12, 2020 Sector: Healthcare Industry: Biotech Market Cap: $4.29B Activated in VL: True Average Daily Range Avg Daily Range: $1.02 | 2.53% Avg Daily Range (30 D): $0.51 | 1.56% Avg Daily Range (90 D): $0.79 | 2.37% Institutional Daily Volume Avg Daily Volume: .58M Avg Daily Volume (30 D): 1.16M Avg Daily Volume (90 D): 1.35M Trade Size Avg Trade Size (Sh.): 60 Avg Trade Size (Sh.) (30 D): 58 Avg Trade Size (Sh.) (90 D): 61 Institutional Trades Total Inst.Trades: 3,407 Avg Inst. Trade: $3.73M Avg Inst. Trade (30 D): $2.65M Avg Inst. Trade (90 D): $3.53M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $7.34M Avg Closing Trade (30 D): $6.36M Avg Closing Trade (90 D): $8.67M Avg Closing Volume: 137.19K     News Aug 21, 2025 @ 5:00 PM Pneumococcal Infections Clinical Trial Analysis: K... Source: Delveinsight Aug 7, 2025 @ 12:19 AM Vaxcyte (PCVX) Q2 Loss Widens 11% Source: Jesterai Mar 31, 2025 @ 12:56 PM Vaxcyte Plans To Drop Developing One Pneumococcal ... Source: Vandana Singh Jan 30, 2025 @ 4:51 PM Kuehn Law Encourages Investors of Vaxcyte, Inc. to... Source: N/A Jan 1, 2025 @ 9:27 AM Trump and Interest Rates: The 2 Key Reasons This V... Source: Anthony Di Pizio Financials   TTM Q2 2025 Q1 2025 Basic EPS $-4.11 $-1.22 $-1.04 Diluted EPS $-4.11 $-1.22 $-1.04 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -547.5M $ -166.57M $ -140.72M Operating Income / Loss $ -709.11M $ -226.22M $ -180.79M Cost of Revenue $ $ $ Net Cash Flow $ -211.71M $ -40.11M $ -41.03M PE Ratio